Roman DBDR Tech Sponsor LLC - Apr 25, 2023 Form 4 Insider Report for CompoSecure, Inc. (CMPO)

Role
10%+ Owner
Signature
/s/ Dr. Donald G. Basile, as Authorized Signatory
Stock symbol
CMPO
Transactions as of
Apr 25, 2023
Transactions value $
-$272,616
Form type
4
Date filed
4/27/2023, 06:31 PM
Previous filing
Apr 21, 2023
Next filing
May 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPO Warrant Sale -$111K -85.5K -0.93% $1.30 9.12M Apr 25, 2023 Class A Common Stock 85.5K $11.50 Direct F1, F2
transaction CMPO Warrant Sale -$105K -81K -0.89% $1.30 9.04M Apr 26, 2023 Class A Common Stock 81K $11.50 Direct F2
transaction CMPO Warrant Sale -$56.1K -43.1K -0.48% $1.30 9M Apr 27, 2023 Class A Common Stock 43.1K $11.50 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 8 is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $1.30 to $1.315, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants sold at each separate price within the ranges set forth in footnotes 1 and 3 to this Form 4.
F2 Dr. Donald G. Basile, Chairman and Co-Chief Executive Officer of the registrant and Dixon Doll, Jr., the registrant's Co-Chief Executive Officer, are the managing members of the reporting person and have voting and investment discretion with respect to the securities held by the reporting person. As such, Messrs. Basile and Doll may be deemed to share beneficial ownership of the warrants held directly by the reporting person. Each of Messrs. Basile and Doll disclaim any beneficial ownership of the reported warrants other than to the extent of any pecuniary interest they may have therein, directly or indirectly.
F3 The price reported in Column 8 is a weighted average price. These warrants were sold in multiple transactions at prices ranging from $1.30 to $1.31, inclusive.